The most common form of heart disease is myocardial ischemia, which is characterized by an insufficient supply of blood, substrates and oxygen to the heart due to coronary artery obstruction. If not treated, irreversible damage ensues in the form of myocardial infarction (heart attack). The overall aim of the Project is to identify mechanisms which are fundamental to the understanding of ischemic heart disease, which will be accomplished by utilizing an integrative approach including cellular and molecular studies as well as integrative whole animal physiology. Project 1 involves the study of the mechanisms of cardiac protection in the second window of ischemic protection (SWOP) in chronically instrumented conscious swine. One unique aspect of this Project is the use of the large mammalian model, which resembles pathophysiology in humans more closely than rodents, lacks preformed coronary collateral vessels, and the heart is sufficiently large to provide measurements of regional function, blood flow, biochemistry, molecular biology and pathology from the same animals in both the ischemic zone and a contralateral, remote, non-ischemic zone. The project is based, in part, on the novel observation that either regional cardiac denervation or adrenergic receptor blockade abrogates the second window of protection. There are three major hypotheses: A)SWOP is critically dependent on the sympathetic nervous system;B)Regional cardiac denervation alters SWOP in the remote, non-ischemic zone;C)SWOP results in enhanced long chain fatty acid (LCFA) oxidation during ischemia, potentially due to AMP kinase elevation, an effect which is abolished following SWOP in conscious pigs with regional cardiac denervation. Project 1 is tied closely to the other projects and cores, as well as to the major themes of the Program Project, which are: 1)Mechanisms of myocardial ischemia and reperfusion; 2)Molecular signaling;3)Myocardial protection and cell survival vs. cell death;4)lntegrative cardiovascular research. This project is also linked closely to Project 2, which also studies the chronically instrumented swine model, but in Project 2 the model is one of repetitive stunning (myocardial hibernation). Indeed, several of the aims are shared by Projects 1 and 2, since the two projects will address several of the same questions in the two different models. Project 1 interacts with Project 3 in terms of molecular signaling and mechanisms of apoptosis, and with Project 4 particularly related to H11 kinase, which will be administered to pigs with regional cardiac denervation, to determine if H11 kinase can restore protection after cardiac denervation. Project 1 also utilizes all of the Cores.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL069020-09
Application #
7907572
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
9
Fiscal Year
2009
Total Cost
$323,925
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Vatner, Dorothy E; Zhang, Jie; Oydanich, Marko et al. (2018) Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14. Aging Cell :e12751
Guers, John J; Zhang, Jie; Campbell, Sara C et al. (2017) Disruption of adenylyl cyclase type 5 mimics exercise training. Basic Res Cardiol 112:59
Zhang, Jie; Zhao, Xin; Vatner, Dorothy E et al. (2016) Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates. Arterioscler Thromb Vasc Biol 36:700-6
Vatner, Stephen F (2016) Why So Few New Cardiovascular Drugs Translate to the Clinics. Circ Res 119:714-7
Jose Corbalan, J; Vatner, Dorothy E; Vatner, Stephen F (2016) Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol 111:31
Bravo, Claudio A; Vatner, Dorothy E; Pachon, Ronald et al. (2016) A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion. J Pharmacol Exp Ther 357:331-6
Sciarretta, Sebastiano; Yee, Derek; Ammann, Paul et al. (2015) Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes. Clin Sci (Lond) 128:387-403
Yuan, Chujun; Yan, Lin; Solanki, Pallavi et al. (2015) Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis. J Mol Cell Cardiol 79:224-31
Ho, David; Zhao, Xin; Yan, Lin et al. (2015) Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance. Diabetes 64:2636-45
Yan, Lin; Kudej, Raymond K; Vatner, Dorothy E et al. (2015) Myocardial ischemic protection in natural mammalian hibernation. Basic Res Cardiol 110:9

Showing the most recent 10 out of 196 publications